News & Updates
Filter by Specialty:
Delaying endoscopies due to COVID-19 safe in IBD patients
Delays in endoscopies due to the coronavirus disease 2019 (COVID-19) pandemic does not seem to worsen clinical outcomes in patients with inflammatory bowel diseases (IBD), though healthcare utilization patterns appear to be affected, according to a study reported at the recently concluded 2022 Crohn’s & Colitis Congress (CCC 2022).
Delaying endoscopies due to COVID-19 safe in IBD patients
14 Feb 2022
Sexual dysfunction linked to psychological factors, but not IBD severity
In patients with inflammatory bowel disease (IBD), erectile and sexual dysfunction (SD) are significantly associated with psychological factors, but IBD severity appears to have no impact on such conditions, suggests a recent study. Likewise, the type of medication used to treat the underlying disease has no influence on SD development.
Sexual dysfunction linked to psychological factors, but not IBD severity
13 Feb 2022
No benefit to adding 5-ASAs to steroids in acute severe UC
The addition of 5-aminosalicylic acid (5-ASA) to standard corticosteroid treatment did not improve outcomes in patients hospitalized with acute severe ulcerative colitis (UC), according to a study presented at the Crohn’s and Colitis Congress 2022.
No benefit to adding 5-ASAs to steroids in acute severe UC
11 Feb 2022
Sleep problems plague IBD patients, require more attention
The opinion that inflammatory bowel disease (IBD) is associated with poor sleep is not uncommon among patients with IBD, according to a study. Moreover, these individuals tend to think and behave in manners that worsen sleep and their disease.
